{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:49:23Z","timestamp":1794541763150,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07426-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:36:48Z","timestamp":1764171408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Probiotics lead to a new frontier in tumor fighting: tumor vaccines based on probiotics"],"prefix":"10.1186","volume":"23","author":[{"given":"Tingting","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-4640","authenticated-orcid":false,"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"7426_CR1","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui R, Zhou L, He S. Cancer immunotherapies: advances and bottlenecks. Front Immunol. 2023;14:1212476. https:\/\/doi.org\/10.3389\/fimmu.2023.1212476. PMID: 37691932; PMCID: PMC10484345. 37691932; PMCID: PMC10484345.","journal-title":"Front Immunol"},{"issue":"4","key":"7426_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","volume":"18","author":"E Blass","year":"2021","unstructured":"Blass E, Ott PA. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines. Nat Rev Clin Oncol. 2021;18(4):215\u201329. https:\/\/doi.org\/10.1038\/s41571-020-00460-2. Epub 2021 Jan 20. PMID: 33473220; PMCID: PMC7816749.","journal-title":"Nat Rev Clin Oncol"},{"key":"7426_CR3","doi-asserted-by":"publisher","unstructured":"Shen X, Zhu C, Liu X, Zheng H, Wu Q, Xie J, et al. Engineered bacteria for augmented in situ tumor vaccination. Biomater Sci. 2023;11(4):1137\u20131152. https:\/\/doi.org\/10.1039\/d2bm01593e. PMID: 36601796.","DOI":"10.1039\/d2bm01593e"},{"key":"7426_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/ITT.S202006","volume":"9","author":"S Guallar-Garrido","year":"2020","unstructured":"Guallar-Garrido S, Juli\u00e1n E. Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update. Immunotargets Ther. 2020;9:1\u201311. https:\/\/doi.org\/10.2147\/ITT.S202006. PMID: 32104666; PMCID: PMC7025668.","journal-title":"Immunotargets Ther"},{"key":"7426_CR5","doi-asserted-by":"publisher","unstructured":"Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012. PMID: 23890059.","DOI":"10.1016\/j.immuni.2013.07.012"},{"key":"7426_CR6","doi-asserted-by":"publisher","unstructured":"Parmiani G, De Filippo A, Novellino L, Castelli C. Unique human tumor antigens: immunobiology and use in clinical trials. J Immunol. 2007;178(4):1975-9. https:\/\/doi.org\/10.4049\/jimmunol.178.4.1975. PMID: 17277099.","DOI":"10.4049\/jimmunol.178.4.1975"},{"key":"7426_CR10","doi-asserted-by":"publisher","first-page":"1002674","DOI":"10.3389\/fimmu.2022.1002674","volume":"13","author":"S Singh","year":"2022","unstructured":"Singh S, Singh M, Gaur S. Probiotics as multifaceted oral vaccines against colon cancer: a review. Front Immunol. 2022;13:1002674. https:\/\/doi.org\/10.3389\/fimmu.2022.1002674. PMID: 36263037; PMCID: PMC9573965.","journal-title":"Front Immunol"},{"key":"7426_CR7","doi-asserted-by":"publisher","unstructured":"Ma F, Li Z, Liu H, Chen S, Zheng S, Zhu J, et al. Dietary-timing-induced gut microbiota diurnal oscillations modulate inflammatory rhythms in rheumatoid arthritis. Cell Metab. 2024;S1550-4131(24)00334-6. https:\/\/doi.org\/10.1016\/j.cmet.2024.08.007. Epub ahead of print. PMID: 39260371.","DOI":"10.1016\/j.cmet.2024.08.007"},{"key":"7426_CR8","doi-asserted-by":"publisher","unstructured":"Ruxton CHS, Kajita C, Rocca P, Pot B. Microbiota and probiotics: chances and challenges - a symposium report. Gut Microbiome (Camb). 2023;4:e6. https:\/\/doi.org\/10.1017\/gmb.2023.4. PMID: 39295904; PMCID: PMC11406417.","DOI":"10.1017\/gmb.2023.4"},{"issue":"1","key":"7426_CR9","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu J, Ke Y, Liu Q, Yang J, Liu F, Xu R, Zhou H, Chen A, Xiao J, Meng F, Yu L, Li R, Wei J, Liu B. Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy. Nat Commun. 2022;13(1):7466. https:\/\/doi.org\/10.1038\/s41467-022-35130-7. PMID: 36463242; PMCID. PMC9719518.","journal-title":"Nat Commun"},{"issue":"1","key":"7426_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/1078-0432.CCR-20-2065","volume":"27","author":"F Janku","year":"2021","unstructured":"Janku F, Zhang HH, Pezeshki A, Goel S, Murthy R, Wang-Gillam A, Shepard DR, Helgason T, Masters T, Hong DS, Piha-Paul SA, Karp DD, Klang M, Huang SY, Sakamuri D, Raina A, Torrisi J, Solomon SB, Weissfeld A, Trevino E, DeCrescenzo G, Collins A, Miller M, Salstrom JL, Korn RL, Zhang L, Saha S, Leontovich AA, Tung D, Kreider B, Varterasian M, Khazaie K, Gounder MM. Intratumoral injection of clostridium novyi-NT spores in patients with Treatment-refractory advanced solid tumors. Clin Cancer Res. 2021;27(1):96\u2013106. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2065. Epub 2020 Oct 12. PMID: 33046513.","journal-title":"Clin Cancer Res"},{"key":"7426_CR12","doi-asserted-by":"publisher","unstructured":"Toussaint B, Chauchet X, Wang Y, Polack B, Le Gou\u00ebllec A. Live-attenuated bacteria as a cancer vaccine vector. Expert Rev Vaccines. 2013;12(10):1139-54. https:\/\/doi.org\/10.1586\/14760584.2013.836914. PMID: 24124876.","DOI":"10.1586\/14760584.2013.836914"},{"issue":"11","key":"7426_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrc2934","volume":"10","author":"NS Forbes","year":"2010","unstructured":"Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer. 2010;10(11):785\u201394. https:\/\/doi.org\/10.1038\/nrc2934. Epub 2010 Oct 14. PMID: 20944664; PMCID: PMC3756932. 20944664; PMCID: PMC3756932.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"7426_CR14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41591-019-0410-x","volume":"25","author":"L Hammerich","year":"2019","unstructured":"Hammerich L, Marron TU, Upadhyay R, Svensson-Arvelund J, Dhainaut M, Hussein S, Zhan Y, Ostrowski D, Yellin M, Marsh H, Salazar AM, Rahman AH, Brown BD, Merad M, Brody JD. Systemic clinical tumor regressions and potentiation of PD1 Blockade with in situ vaccination. Nat Med. 2019;25(5):814\u201324. https:\/\/doi.org\/10.1038\/s41591-019-0410-x. Epub 2019 Apr 8. PMID: 30962585.","journal-title":"Nat Med"},{"key":"7426_CR15","doi-asserted-by":"publisher","unstructured":"Demaria O, Cornen S, Da\u00ebron M, Morel Y, Medzhitov R, Vivier E. Harnessing innate immunity in cancer therapy. Nature. 2019;574(7776):45\u201356. https:\/\/doi.org\/10.1038\/s41586-019-1593-5. Epub 2019 Oct 2. Erratum in: Nature. 2019;576(7785):E3. https:\/\/doi.org\/10.1038\/s41586-019-1758-2. PMID: 31578484.","DOI":"10.1038\/s41586-019-1593-5"},{"key":"7426_CR16","doi-asserted-by":"publisher","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541(7637):321\u2013330. https:\/\/doi.org\/10.1038\/nature21349. PMID: 28102259.","DOI":"10.1038\/nature21349"},{"issue":"7","key":"7426_CR17","doi-asserted-by":"publisher","first-page":"2003572","DOI":"10.1002\/advs.202003572","volume":"8","author":"X Huang","year":"2021","unstructured":"Huang X, Pan J, Xu F, Shao B, Wang Y, Guo X, Zhou S. Bacteria-Based Cancer Immunotherapy Adv Sci (Weinh). 2021;8(7):2003572. https:\/\/doi.org\/10.1002\/advs.202003572. PMID: 33854892; PMCID: PMC8025040.","journal-title":"Bacteria-Based Cancer Immunotherapy Adv Sci (Weinh)"},{"issue":"1","key":"7426_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","volume":"6","author":"W Wang","year":"2022","unstructured":"Wang W, Xu H, Ye Q, Tao F, Wheeldon I, Yuan A, Hu Y, Wu J. Systemic immune responses to irradiated tumors via the transport of antigens to the tumor periphery by injected flagellate bacteria. Nat Biomed Eng. 2022;6(1):44\u201353. https:\/\/doi.org\/10.1038\/s41551-021-00834-6. Epub 2022 Jan 20. PMID: 35058589.","journal-title":"Nat Biomed Eng"},{"key":"7426_CR19","doi-asserted-by":"publisher","unstructured":"Wei B, Pan J, Yuan R, Shao B, Wang Y, Guo X, et al. Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy. Nano Lett. 2021;21(10):4231\u20134240. https:\/\/doi.org\/10.1021\/acs.nanolett.1c00209. Epub 2021 May 17. Erratum in: Nano Lett. 2021;21(13):5905. https:\/\/doi.org\/10.1021\/acs.nanolett.1c02272. Erratum in: Nano Lett. 2022;22(1):543. https:\/\/doi.org\/10.1021\/acs.nanolett.1c04545. Nanolett.1c04501. PMID: 33998789.","DOI":"10.1021\/acs.nanolett.1c00209"},{"issue":"12","key":"7426_CR20","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1021\/acs.nanolett.2c00699","volume":"22","author":"M Sun","year":"2022","unstructured":"Sun M, Yang S, Huang H, Gao P, Pan S, Cheng Z, He Z, Wang Z, Sun J, Liu F. Boarding oncolytic viruses onto Tumor-Homing Bacterium-Vessels for augmented cancer immunotherapy. Nano Lett. 2022;22(12):5055\u201364. https:\/\/doi.org\/10.1021\/acs.nanolett.2c00699. Epub 2022 May 18. PMID: 35583490.","journal-title":"Nano Lett"},{"key":"7426_CR21","doi-asserted-by":"publisher","first-page":"114321","DOI":"10.1016\/j.addr.2022.114321","volume":"186","author":"Q Long","year":"2022","unstructured":"Long Q, Zheng P, Zheng X, Li W, Hua L, Yang Z, Huang W, Ma Y. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy. Adv Drug Deliv Rev. 2022;186:114321. https:\/\/doi.org\/10.1016\/j.addr.2022.114321. Epub 2022 May 6. PMID: 35533789.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"7426_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41467-017-00729-8","volume":"8","author":"OY Kim","year":"2017","unstructured":"Kim OY, Park HT, Dinh NTH, Choi SJ, Lee J, Kim JH, Lee SW, Gho YS. Bacterial outer membrane vesicles suppress tumor by interferon-\u03b3-mediated antitumor response. Nat Commun. 2017;8(1):626. https:\/\/doi.org\/10.1038\/s41467-017-00729-8. PMID: 28931823; PMCID: PMC5606984.","journal-title":"Nat Commun"},{"key":"7426_CR23","doi-asserted-by":"publisher","unstructured":"Li Y, Zhao R, Cheng K, Zhang K, Wang Y, Zhang Y, et al. Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint inhibition. ACS Nano. 2020;14(12):16698\u201316711. https:\/\/doi.org\/10.1021\/acsnano.0c03776. epub 2020 Nov 24. PMID: 33232124.","DOI":"10.1021\/acsnano.0c03776"},{"key":"7426_CR24","doi-asserted-by":"publisher","unstructured":"Qing S, Lyu C, Zhu L, Pan C, Wang S, Li F, et al. Biomineralized bacterial outer membrane vesicles potentiate safe and efficient tumor microenvironment reprogramming for anticancer therapy. Adv Mater. 2020;32(47):e2002085. https:\/\/doi.org\/10.1002\/adma.202002085. epub 2020 Oct 5. PMID: 33015871.","DOI":"10.1002\/adma.202002085"},{"issue":"1","key":"7426_CR25","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/s41467-021-22308-8","volume":"12","author":"K Cheng","year":"2021","unstructured":"Cheng K, Zhao R, Li Y, Qi Y, Wang Y, Zhang Y, Qin H, Qin Y, Chen L, Li C, Liang J, Li Y, Xu J, Han X, Anderson GJ, Shi J, Ren L, Zhao X, Nie G. Bioengineered bacteria- derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nat Commun. 2021;12(1):2041. https:\/\/doi.org\/10.1038\/s41467-021-22308-8. PMID: 33824314; PMCID: PMC8024398.","journal-title":"Nat Commun"},{"issue":"48","key":"7426_CR26","doi-asserted-by":"publisher","first-page":"21562","DOI":"10.1002\/anie.202002649","volume":"59","author":"QW Chen","year":"2020","unstructured":"Chen QW, Wang JW, Wang XN, Fan JX, Liu XH, Li B, Han ZY, Cheng SX, Zhang XZ. Inhibition of tumor progression through the coupling of bacterial respiration with tumor metabolism. Angew Chem Int Ed Engl. 2020;59(48):21562\u201370. https:\/\/doi.org\/10.1002\/anie.202002649. Epub 2020 Sep 15. PMID: 32779303.","journal-title":"Angew Chem Int Ed Engl"},{"key":"7426_CR39","doi-asserted-by":"publisher","unstructured":"Sun M, Shi T, Tuerhong S, Li M, Wang Q, Lu C, et al. An immunomodulator-boosted Lactococcus lactis platform for enhanced in situ tumor vaccine. Adv Healthc Mater. 2024;e2401635. https:\/\/doi.org\/10.1002\/adhm.202401635. Epub ahead of print. PMID: 39054611.","DOI":"10.1002\/adhm.202401635"},{"key":"7426_CR27","doi-asserted-by":"publisher","unstructured":"Vitiello A, Zanetti M. Neoantigen prediction and the need for validation. Nat Biotechnol. 2017;35(9):815\u2013817. https:\/\/doi.org\/10.1038\/nbt.3932. PMID. 28898209.","DOI":"10.1038\/nbt.3932"},{"key":"7426_CR28","doi-asserted-by":"publisher","first-page":"120709","DOI":"10.1016\/j.biomaterials.2021.120709","volume":"270","author":"F Chen","year":"2021","unstructured":"Chen F, Wang Y, Gao J, Saeed M, Li T, Wang W, Yu H. Nanobiomaterial-based vaccination immunotherapy of cancer. Biomaterials. 2021;270:120709. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120709. epub 2021 Feb 5. PMID: 33581608.","journal-title":"Biomaterials"},{"issue":"8038","key":"7426_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","volume":"635","author":"A Redenti","year":"2024","unstructured":"Redenti A, Im J, Redenti B, Li F, Rouanne M, Sheng Z, Sun W, Gurbatri CR, Huang S, Komaranchath M, Jang Y, Hahn J, Ballister ER, Vincent RL, Vardoshivilli A, Danino T, Arpaia N. Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature. 2024;635(8038):453\u201361. https:\/\/doi.org\/10.1038\/s41586-024-08033-4. Epub 2024 Oct 16. PMID: 39415001.","journal-title":"Nature"},{"issue":"6641","key":"7426_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.abp9563","volume":"380","author":"YE Chen","year":"2023","unstructured":"Chen YE, Bousbaine D, Veinbachs A, Atabakhsh K, Dimas A, Yu VK, Zhao A, Enright NJ, Nagashima K, Belkaid Y, Fischbach MA. Engineered skin bacteria induce antitumor T-cell responses against melanoma. Science. 2023;380(6641):203\u201310. https:\/\/doi.org\/10.1126\/science.abp9563. Epub 2023 Apr 13. PMID: 37053311.","journal-title":"Science"},{"key":"7426_CR31","doi-asserted-by":"publisher","unstructured":"Pearlman AH, Hwang MS, Konig MF, Hsiue EH, Douglass J, DiNapoli SR, et al. Targeting public neoantigens for cancer immunotherapy. Nat Cancer. 2021;2(5):487\u2013497. https:\/\/doi.org\/10.1038\/s43018-021-00210-y. Epub 2021 May 17 Erratum in: Nat Cancer. 2021;2(8):865\u2013867. https:\/\/doi.org\/10.1038\/s43018-021-00246-0. PMID: 34676374; PMCID: PMC8525885.","DOI":"10.1038\/s43018-021-00210-y"},{"key":"7426_CR32","doi-asserted-by":"publisher","unstructured":"Bartolomeo R, Troise F, Allocca S, Sdruscia G, Vitale R, Bignone V, et al. Development of a potency assay for Nous-209, a multivalent neoantigens-based genetic cancer vaccine. Vaccines (Basel). 2024;12(3):325. https:\/\/doi.org\/10.3390\/vaccines12030325. PMID: 38543959; PMCID: PMC10975996.","DOI":"10.3390\/vaccines12030325"},{"issue":"18","key":"7426_CR33","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1158\/0008-5472.CAN-20-1072","volume":"80","author":"G Leoni","year":"2020","unstructured":"Leoni G, D\u2019Alise AM, Cotugno G, Langone F, Garzia I, De Lucia M, Fichera I, Vitale R, Bignone V, Tucci FG, Mori F, Leuzzi A, Di Matteo E, Troise F, Abbate A, Merone R, Ruzza V, Diodoro MG, Yadav M, Gordon-Alonso M, Vanhaver C, Panigada M, Soprana E, Siccardi A, Merone R, Ruzza V, Diodoro MG, Yadav M, Gordon-Alonso M, Vanhaver C, Panigada M, Soprana E, Siccardi A, Folgori A, Colloca S, van der Bruggen P, Nicosia A, Lahm A, Catanese MT, Scarselli E. A genetic vaccine encoding shared cancer neoantigens to treat tumors with microsatellite instability. Cancer Res. 2020;80(18):3972\u201382. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1072. Epub 2020 Jul 20. PMID: 32690723.","journal-title":"Cancer Res"},{"issue":"7","key":"7426_CR34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41551-022-00886-2","volume":"6","author":"Y Yue","year":"2022","unstructured":"Yue Y, Xu J, Li Y, Cheng K, Feng Q, Ma X, Ma N, Zhang T, Wang X, Zhao X, Nie G. Antigen-bearing outer membrane vesicles as tumor vaccines produced in situ by ingested genetically engineered bacteria. Nat Biomed Eng. 2022;6(7):898\u2013909. https:\/\/doi.org\/10.1038\/s41551-022-00886-2. Epub 2022 May 2. PMID: 35501399.","journal-title":"Nat Biomed Eng"},{"issue":"45","key":"7426_CR35","doi-asserted-by":"publisher","first-page":"e2004529","DOI":"10.1002\/adma.202004529","volume":"32","author":"DW Zheng","year":"2020","unstructured":"Zheng DW, Li RQ, An JX, Xie TQ, Han ZY, Xu R, Fang Y, Zhang XZ. Prebiotics-Encapsulated probiotic spores regulate gut microbiota and suppress colon cancer. Adv Mater. 2020;32(45):e2004529. https:\/\/doi.org\/10.1002\/adma.202004529. Epub 2020 Oct 1. PMID: 33006175.","journal-title":"Adv Mater"},{"key":"7426_CR36","doi-asserted-by":"publisher","unstructured":"Ho CL, Tan HQ, Chua KJ, Kang A, Lim KH, Ling KL, et al. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nat Biomed Eng. 2018;2(1):27\u201337. https:\/\/doi.org\/10.1038\/s41551-017-0181-y. Epub 2018 Jan 10. Erratum in: Nat Biomed Eng. 2020;4(7). 754\u2013755. https:\/\/doi.org\/10.1038\/s41551-020-0580-3. PMID: 31015663.","DOI":"10.1038\/s41551-017-0181-y"},{"issue":"1","key":"7426_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7774\/cevr.2017.6.1.15","volume":"6","author":"SH Kim","year":"2017","unstructured":"Kim SH, Jang YS. The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants. Clin Exp Vaccine Res. 2017;6(1):15\u201321. https:\/\/doi.org\/10.7774\/cevr.2017.6.1.15. Epub 2017 Jan 25. PMID: 28168169; PMCID: PMC5292352.","journal-title":"Clin Exp Vaccine Res"},{"issue":"1","key":"7426_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","volume":"15","author":"CR Gurbatri","year":"2024","unstructured":"Gurbatri CR, Radford GA, Vrbanac L, Im J, Thomas EM, Coker C, Taylor SR, Jang Y, Sivan A, Rhee K, Saleh AA, Chien T, Zandkarimi F, Lia I, Lannagan TRM, Wang T, Wright JA, Kobayashi H, Ng JQ, Lawrence M, Sammour T, Thomas M, Lewis M, Papanicolas L, Perry J, Fitzsimmons T, Kaazan P, Lim A, Stavropoulos AM, Gouskos DA, Marker J, Ostroff C, Rogers G, Arpaia N, Worthley DL, Woods SL, Danino T. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nat Commun. 2024;15(1):646. https:\/\/doi.org\/10.1038\/s41467-024-44776-4. PMID: 38245513; PMCID: PMC10799955.","journal-title":"Nat Commun"},{"issue":"5","key":"7426_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761\u201373. https:\/\/doi.org\/10.7150\/jca.17648. PMID: 28382138; PMCID: PMC5381164.","journal-title":"J Cancer"},{"key":"7426_CR42","doi-asserted-by":"publisher","unstructured":"Ott PA, Hu-Lieskovan S, Chmielowski B, Govindan R, Naing A, Bhardwaj N, et al. A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer. Cell. 2020;183(2):347\u2013362.e24. https:\/\/doi.org\/10.1016\/j.cell.2020.08.053. PMID: 33064988.","DOI":"10.1016\/j.cell.2020.08.053"},{"issue":"1","key":"7426_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41541-022-00433-9","volume":"7","author":"E Salvatori","year":"2022","unstructured":"Salvatori E, Lione L, Compagnone M, Pinto E, Conforti A, Ciliberto G, Aurisicchio L, Palombo F. Neoantigen cancer vaccine augments anti-CTLA-4 efficacy. Npj Vaccines. 2022;7(1):15. https:\/\/doi.org\/10.1038\/s41541-022-00433-9. PMID: 35110563; PMCID: PMC8810847.","journal-title":"Npj Vaccines"},{"issue":"1","key":"7426_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13045-018-0684-3","volume":"11","author":"Z Li","year":"2018","unstructured":"Li Z, Song W, Rubinstein M, Liu D. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China cancer immunotherapy workshop in Beijing. J Hematol Oncol. 2018;11(1):142. https:\/\/doi.org\/10.1186\/s13045-018-0684-3. PMID: 30577797; PMCID: PMC6303854.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"7426_CR45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.023","volume":"108","author":"EB Golden","year":"2020","unstructured":"Golden EB, Marciscano AE, Formenti SC. Radiation therapy and the in situ vaccination approach. Int J Radiat Oncol Biol Phys. 2020;108(4):891\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.023. Epub 2020 Aug 12. PMID: 32800803.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7426_CR46","doi-asserted-by":"publisher","unstructured":"Ashrafizadeh M, Farhood B, Musa AE, Taeb S, Rezaeyan A, Najafi M. Abscopal effect in radioimmunotherapy. Int Immunopharmacol. 2020;85:106663. https:\/\/doi.org\/10.1016\/j.intimp.2020.106663. epub 2020 Jun 7. PMID: 32521494.","DOI":"10.1016\/j.intimp.2020.106663"},{"issue":"12","key":"7426_CR50","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1158\/1078-0432.CCR-19-2034","volume":"26","author":"A Arina","year":"2020","unstructured":"Arina A, Gutiontov SI, Weichselbaum RR. Radiotherapy and immunotherapy for cancer: from systemic to multisite. Clin Cancer Res. 2020;26(12):2777\u201382. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2034. Epub 2020 Feb 11. PMID: 32047000; PMCID: PMC10759929.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"7426_CR47","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/jnci\/djaa190","volume":"113","author":"HM McGee","year":"2021","unstructured":"McGee HM, Marciscano AE, Campbell AM, Monjazeb AM, Kaech SM, Teijaro JR. Parallels between the antiviral state and the irradiated state. J Natl Cancer Inst. 2021;113(8):969\u201379. https:\/\/doi.org\/10.1093\/jnci\/djaa190. PMID: 33252657; PMCID: PMC8502484.","journal-title":"J Natl Cancer Inst"},{"issue":"Pt 2","key":"7426_CR48","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.semcancer.2022.04.003","volume":"86","author":"M Charpentier","year":"2022","unstructured":"Charpentier M, Spada S, Van Nest SJ, Demaria S. Radiation therapy-induced remodeling of the tumor immune microenvironment. Semin Cancer Biol. 2022;86(Pt 2):737\u201347. https:\/\/doi.org\/10.1016\/j.semcancer.2022.04.003. Epub 2022 Apr 9. PMID: 35405340.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"7426_CR49","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12967-023-04504-w","volume":"21","author":"Z Sun","year":"2023","unstructured":"Sun Z, Chu Y, Xiao J, Yang Y, Meng F, Wang X, Dong Y, Zhu J, Wu Y, Qin L, Ke Y, Liu B, Liu Q. Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy. J Transl Med. 2023;21(1):619. https:\/\/doi.org\/10.1186\/s12967-023-04504-w. PMID: 37700338; PMCID. PMC10498626.","journal-title":"J Transl Med"},{"issue":"1","key":"7426_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/14712598.2017.1256388","volume":"17","author":"E Beyranvand Nejad","year":"2017","unstructured":"Beyranvand Nejad E, Welters MJ, Arens R, van der Burg SH. The importance of correctly timing cancer immunotherapy. Expert Opin Biol Ther. 2017;17(1):87\u2013103. Epub 2016 Nov 16. PMID: 27802061.","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"7426_CR52","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ijrobp.2013.12.043","volume":"88","author":"M Witek","year":"2014","unstructured":"Witek M, Blomain ES, Magee MS, Xiang B, Waldman SA, Snook AE. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C. Int J Radiat Oncol Biol Phys. 2014;88(5):1188\u201395. PMID: 24661671; PMCID: PMC3967134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7426_CR40","doi-asserted-by":"publisher","unstructured":"Yang S, Sheffer M, Kaplan IE, Wang Z, Tarannum M, Dinh K, et al. Nonpathogenic E. coli displaying decoy- resistant IL18 Mutein boosts anti-tumor and CAR NK cell responses. Nat Biotechnol. 2024. https:\/\/doi.org\/10.1038\/s41587-024-02418-6. Epub ahead of print. PMID: 39367093.","DOI":"10.1038\/s41587-024-02418-6"},{"issue":"5","key":"7426_CR53","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41551-024-01191-w","volume":"8","author":"C Wang","year":"2024","unstructured":"Wang C, Zhong L, Xu J, Zhuang Q, Gong F, Chen X, Tao H, Hu C, Huang F, Yang N, Li J, Zhao Q, Sun X, Huo Y, Chen Q, Zhao Y, Peng R, Liu Z. Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nat Biomed Eng. 2024;8(5):561\u201378. https:\/\/doi.org\/10.1038\/s41551-024-01191-w. Epub 2024 Mar 21. PMID: 38514774. 38514774.","journal-title":"Nat Biomed Eng"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07426-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07426-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07426-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:36:48Z","timestamp":1764171408000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07426-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7426"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07426-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1358"}}